Sale!

VSX1 Gene Craniofacial Anomalies and Anterior Segment Dysgenesis Syndrome NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The VSX1 Gene Craniofacial Anomalies and Anterior Segment Dysgenesis Syndrome NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the VSX1 gene, which plays a critical role in eye development and craniofacial formation. This comprehensive next-generation sequencing test provides definitive diagnosis for individuals presenting with congenital eye abnormalities, facial dysmorphism, and developmental eye disorders. The test helps identify specific genetic variants responsible for conditions affecting the anterior segment of the eye and facial structures, enabling targeted treatment approaches and genetic counseling. At $500 USD, this advanced genetic analysis offers families clarity about inherited conditions and supports informed medical decision-making for affected individuals.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

VSX1 Gene Craniofacial Anomalies and Anterior Segment Dysgenesis Syndrome NGS Genetic DNA Test

Understanding VSX1 Gene Disorders

The VSX1 gene plays a fundamental role in ocular development and craniofacial formation during embryonic growth. Mutations in this critical gene can lead to a spectrum of congenital abnormalities affecting both eye structures and facial development. Our advanced NGS genetic testing provides comprehensive analysis of the VSX1 gene to identify pathogenic variants responsible for these complex developmental disorders.

What Does This Test Measure?

This sophisticated genetic test utilizes next-generation sequencing technology to thoroughly examine the entire VSX1 gene for mutations and variations. The test specifically detects:

  • Point mutations and single nucleotide variants in the VSX1 gene
  • Small insertions and deletions affecting gene function
  • Pathogenic variants associated with anterior segment dysgenesis
  • Genetic alterations linked to craniofacial developmental abnormalities
  • Inherited and de novo mutations affecting ocular and facial development

Who Should Consider VSX1 Genetic Testing?

This specialized genetic test is recommended for individuals presenting with specific clinical features and family history patterns:

Clinical Indications and Symptoms

  • Congenital corneal opacities or clouding
  • Anterior segment developmental abnormalities
  • Iris hypoplasia or structural iris defects
  • Peters anomaly or other corneal development disorders
  • Craniofacial dysmorphism including facial asymmetry
  • Family history of inherited eye development disorders
  • Unexplained congenital visual impairment
  • Multiple family members with similar ocular abnormalities

Comprehensive Benefits of VSX1 Genetic Testing

Undergoing VSX1 genetic testing provides numerous advantages for patients and families facing these complex conditions:

Diagnostic and Clinical Benefits

  • Definitive Diagnosis: Provides conclusive genetic confirmation of VSX1-related disorders
  • Personalized Treatment Planning: Enables targeted therapeutic approaches based on specific genetic findings
  • Genetic Counseling Support: Facilitates informed family planning decisions and recurrence risk assessment
  • Early Intervention Opportunities: Allows for timely management of ocular and craniofacial abnormalities
  • Comprehensive Care Coordination: Supports multidisciplinary management involving ophthalmology, genetics, and craniofacial specialists

Understanding Your Test Results

Our genetic specialists provide detailed interpretation of your VSX1 test results with comprehensive guidance:

Result Interpretation Framework

  • Positive Result: Identification of a pathogenic VSX1 variant confirms genetic diagnosis and enables targeted management strategies
  • Negative Result: No pathogenic variants detected, though clinical correlation remains essential
  • Variant of Uncertain Significance: Genetic changes with unclear clinical impact requiring ongoing monitoring
  • Carrier Status: Identification of individuals carrying VSX1 mutations without clinical symptoms

Test Details and Pricing

Test Component Details
Test Name VSX1 Gene Craniofacial Anomalies and Anterior Segment Dysgenesis Syndrome NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Methodology Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

To ensure optimal testing outcomes, we recommend the following preparations:

  • Complete clinical history documentation of the patient
  • Genetic counseling session to create detailed family pedigree
  • Documentation of affected family members with similar conditions
  • Comprehensive ophthalmological examination records

Nationwide Testing Availability

We proudly offer VSX1 genetic testing services across the United States with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic testing facilities ensures accessible, reliable testing for patients nationwide.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about genetic eye and facial development disorders impact your family’s future. Our specialized VSX1 genetic testing provides the answers you need for informed medical decisions and comprehensive care planning.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your VSX1 Gene Test. Our genetic specialists are ready to guide you through every step of the testing process and help you understand your results with compassion and expertise.